BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36362518)

  • 1. Pathological Findings in COVID-19 and Non-COVID-19 Vaccine-Associated Lymphadenopathy: A Systematic Review.
    Chua TH; Takano A
    J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 vaccine-associated lymphadenopathy: a review.
    Ciliberti V; Maffei E; Giudice V; Ciancia G; Zeppa P; Caputo A
    Infez Med; 2024; 32(2):119-130. PubMed ID: 38827838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 post-vaccination lymphadenopathy: A review of the use of fine needle aspiration cytology.
    Caputo A; Caleo A; Cozzolino I; Zeppa P; Ciancia G; Ciliberti V
    Cytopathology; 2023 Sep; 34(5):423-432. PubMed ID: 36807950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Response Related to Lymphadenopathy Post COVID-19 Vaccination.
    Ho TC; Shen DH; Chang CC; Chan HP; Chuang KP; Yuan CH; Chen CN; Yang MH; Tyan YC
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kikuchi-Fujimoto Disease Post COVID-19 Vaccination: Case Report and Review of Literature.
    Tan HM; Hue SS; Wee A; See KC
    Vaccines (Basel); 2021 Oct; 9(11):. PubMed ID: 34835182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kikuchi-Fujimoto disease can present as delayed lymphadenopathy after COVID-19 vaccination.
    Kashiwada T; Saito Y; Terasaki Y; Shirakura Y; Shinbu K; Tanaka T; Tanaka Y; Seike M; Gemma A
    Hum Vaccin Immunother; 2022 Nov; 18(5):2071080. PubMed ID: 35583472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kikuchi-Fujimoto's Disease or Histiocytic Necrotizing Lymphadenitis Following mRNA COVID-19 Vaccination: A Rare Case.
    Daghri S; Belmoufid N; Rami A; Al Bouzidi A; Bouanani N
    Cureus; 2022 Apr; 14(4):e24155. PubMed ID: 35592214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kikuchi-Fujimoto Disease Following COVID-19 Infection in a 7-Year-Old Girl: A Case Report and Literature Review.
    Saito Y; Suwa Y; Kaneko Y; Tsujiwaki M; Odagawa Y
    Cureus; 2022 Jul; 14(7):e26540. PubMed ID: 35936128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A familial case of Kikuchi-Fujimoto disease in dizygotic twins.
    Quadir A; Peacock K; Hsu P; Singh-Grewal D; Alexander S
    Pediatr Rheumatol Online J; 2020 Aug; 18(1):62. PubMed ID: 32778173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-limiting COVID-19-associated Kikuchi-Fujimoto disease with heart involvement: case-based review.
    Masiak A; Lass A; Kowalski J; Hajduk A; Zdrojewski Z
    Rheumatol Int; 2022 Feb; 42(2):341-348. PubMed ID: 35024942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal imaging findings including high-resolution 3D T2-weighted imaging for COVID-19 vaccine-associated axillary lymphadenopathy in a patient with breast cancer.
    Shimizu H; Mori N; Ren H; Miyashita M; Sato S; Mugikura S; Takase K
    Radiol Case Rep; 2022 Aug; 17(8):2831-2836. PubMed ID: 35702667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent Kikuchi-Fujimoto Disease Masquerading as Lymphoma Successfully Treated by Anakinra.
    Faheem B; Kumar V; Ashkar H; Komal F; Sultana Y
    Cureus; 2020 Nov; 12(11):e11655. PubMed ID: 33391894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kikuchi-Fujimoto disease following SARS-CoV-2 vaccination.
    Ikeda K; Kakehi E; Adachi S; Kotani K
    BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36414349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 Vaccine-Associated Subclinical Axillary Lymphadenopathy on Screening Mammogram.
    Raj S; Ogola G; Han J
    Acad Radiol; 2022 Apr; 29(4):501-507. PubMed ID: 34906409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kikuchi-Fujimoto Disease Following COVID-19.
    Al Ghadeer HA; AlKadhem SM; AlMajed MS; AlAmer HM; AlHabeeb JA; Alomran SH; AlMajed AS
    Cureus; 2022 Jan; 14(1):e21049. PubMed ID: 35155016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Kikuchi-Fujimoto disease after a cervical lymph node metastasis of mucoepidermoid carcinoma: a case report.
    Higaki M; Kanda T; Ando T; Tani R; Toratani S
    Oral Maxillofac Surg; 2021 Mar; 25(1):133-137. PubMed ID: 32856133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kikuchi-Fujimoto Disease and Prognostic Implications.
    Salamat S; Chan J; Jolly K; Powell G; Harrison K; Ahanger S; Hari C
    Head Neck Pathol; 2020 Mar; 14(1):272-275. PubMed ID: 30888636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case Report: Histiocytic Necrotizing Lymphadenitis (Kikuchi-Fujimoto Disease) Concurrent With Aseptic Meningitis.
    Song Y; Liu S; Song L; Chen H; Bai M; Yan J; Luo T; Liu K; Sun L; Zhao Y
    Front Neurol; 2021; 12():565387. PubMed ID: 33959084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time for Resolution of COVID-19 Vaccine-Related Axillary Lymphadenopathy and Associated Factors.
    Lane EG; Eisen CS; Drotman MB; Dodelzon K; Mema E; Thomas C; Prince MR
    AJR Am J Roentgenol; 2022 Oct; 219(4):559-568. PubMed ID: 35583425
    [No Abstract]   [Full Text] [Related]  

  • 20. Kikuchi-Fujimoto disease as the initial manifestation of systemic lupus erythematosus complicated with macrophage activation syndrome: two case reports and a review of literature.
    Liu C; Jin Y; Huang H; Ding F; Yang Z; Xu X; Bao S; Ma J; Jin Y
    BMC Pediatr; 2022 Nov; 22(1):673. PubMed ID: 36414954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.